Company Profile

Sibannac, Inc. is engaged in creating and selling premium next generation wellness products in the consumer packaging goods space. The Company specializes in creating and selling premium Cannabidiol (CBD) products. In addition to mainstream supplements, the Company is producing Kratom and Hemp-derived Delta-8 THC products for wholesale and retail sales and distribution. The Company operates a food-grade facility that is fully cGMP compliant and is vertically integrated, with product design, manufacturing, sales and marketing. It provides contract manufacturing and white labeling services for independent firms and creates and manages its own brands from the concept phase through to distribution. It has opened its platform to outside clients to offer its marketing and brand-building assets, through its wholly owned subsidiary, The Campus Co., which provides services to wellness brands. Its consumer brands include Converse, Titleist, Coca-Cola, and Supercandy.

Employees

Sector

Drug Retailers

More about the company

Quotes

Date	Price	Change	Volume
30/10/26	US$0.005000	-4.58%	110,000
29/10/26	US$0.005240	+6.94%	487,931
28/10/26	US$0.004900	-14.78%	519,100
27/10/26	US$0.005750	+30.68%	2,811,034
26/10/26	US$0.004400	-.--%	25,000

Real-time OTC Markets

More quotes

Market Closed - OTC Markets 19:55:04 04/06/2026 BST			5-day change	1st Jan Change
0.0110 ^USD	-26.67%		+150.00%	-11.43%

12/04/24	Sibannac, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	CI
26/09/23	Sibannac, Inc. signed a heads-of-terms agreement to acquire Retail Cannabis Franchise Units throughout Ontario, Canada from Allstar Health Brands, Inc..	CI

12/04/24	Sibannac, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	CI
26/09/23	Sibannac, Inc. signed a heads-of-terms agreement to acquire Retail Cannabis Franchise Units throughout Ontario, Canada from Allstar Health Brands, Inc..	CI
22/08/23	Sibannac, Inc. Appoints Karl Gottschalk as CEO of its Subsidiary, Immersive Brand Concepts, Inc	CI
12/06/23	Sibannac, Inc. recently acquired Immersive Concepts, LLC.	CI
15/02/23	Sibannac, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	CI
11/05/22	Sibannac, Inc. (OTCPK : SNNC) entered into a principle agreement to acquire Assets of NOHO, Inc.	CI
15/02/22	Sibannac, Inc. Launching Flagship Brand in Practitioenr Channel	CI
31/01/22	Sibannac, Inc. to Begin Manufacturing Inventory for Its New Flagship Brand	CI
18/01/22	Sibannac, Inc. and Spur Biotech, LLC Enter Letter of Intent to Market Plant Based Vaccine	CI
02/12/21	Sibannac, Inc. Opens Retail Location in Downtown Scottsdale	CI
25/10/21	Sibannac, Inc. and Noho, Inc. Announces the Hire of Eric Manfull as Director of Operations & Logistics	CI
11/04/21	Sibannac, Inc. entered into a Memorandum of Understanding to acquire Stellar Chemical Corp. for $10 million.	CI
30/12/20	Sibannac, Inc. cancelled the acquisition of Richardson Nutritional Center, LLC.	CI

08-13	Sibannac, Inc. (OTCID:SNNC) Enters Into Non-Binding Letter of Intent for Strategic Collaboration and Potential Reverse Merger Focused on Advancing Patient Health Potential	AQ
05-20	Sibannac, Inc. Announces Development of Functional Mushroom Products and Moringa to Expand Wellness Portfolio	AQ
05-14	Sibannac, Inc. (SNNC) Announces Joint Venture With 1120 Management, LLC to Develop State-of-the-Art DEA-Compliant Psilocybin Research Facility in Phoenix, Arizona	AQ
04-23	Sibannac, Inc. Anticipates Surge In Psychedelic Tourism Following Presidential Executive Order Fast-Tracking Reserarch	AQ
04-01	Sibannac, Inc. (OTC:SNNC) Announces Strategic Marketing & Revenue Acceleration Partnership With Small Cap Access	AQ

1 day	-26.67%
1 week	+150.00%
Current month	+120.00%
1 month	+214.29%
3 months	+26.44%
6 months	-29.71%
Current year	-11.43%

Sibannac, Inc. Share Price

Stocks

SNNC

US82572P1003

Drug Retailers

Chart: Sibannac, Inc.

Latest news: Sibannac, Inc.

Press Releases: Sibannac, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Sibannac, Inc.

Cannabis Product Retailers

Company Profile

Quotes

1 week	0		0.01
1 month	0		0.01
Current year	0		0.02
1 year	0		0.02
3 years	0		0.06
5 years	0		0.2
10 years	0		2.33

Manager	Title	Age	Since
Eric Stoll PRN	Corporate Officer/Principal	53	-
David Mersky CEO	Chief Executive Officer	54	28/06/2017
Eric Manfull PRN	Corporate Officer/Principal	-	24/10/2021

Director	Title	Age	Since
David Mersky CHM	Chairman	54	-
Booker Evans BRD	Director/Board Member	79	17/05/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SIBANNAC, INC.	-26.67%	+150.00%	-34.52%	-3.51%	678K
JD HEALTH INTERNATIONAL INC.	+5.89%	+1.33%	-37.23%	+7.17%	15.49B
MATSUKIYOCOCOKARA & CO.	+3.15%	-0.76%	-6.75%	-1.29%	6.5B
TSURUHA HOLDINGS INC.	+2.38%	+0.43%	-16.47%	+1.18%	6.44B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	+2.54%	-1.40%	-51.29%	-38.72%	5.82B
RAIA DROGASIL S.A.	-17.06%	-24.95%	-22.38%	-39.83%	4.9B
YIFENG PHARMACY CHAIN CO., LTD.	+5.00%	+4.34%	+8.35%	-3.08%	4.82B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	+9.99%	+11.56%	+10.83%	-14.87%	3.47B
NAHDI MEDICAL COMPANY	-0.44%	+10.73%	-21.79%	-32.44%	3.16B
SUGI HOLDINGS CO.,LTD.	+1.44%	+3.86%	-21.60%	+28.54%	3.08B
Average	-1.38%	-0.44%	-19.29%	-9.68%	5.37B
Weighted average by Cap.	+2.24%	-0.71%	-22.22%	-7.29%